Matthew Stanley, D.O., vice president, behavioral health clinical service line, Avera Health (South Dakota) is the 2023 chair of AHA’s Committee on Behavioral Health. Jill Howard, R.N., assistant vice president, behavioral health, Lifepoint Health (Tennessee), will serve as the 2023 chair-elect, and Arpan Waghray, M.D., CEO, Well-Being Trust (Washington) will serve as the 2023 past-chair. 
 
Joining the committee as members are Nathaniel Clark, M.D., chief medical officer and behavioral health chief of staff, Vanderbilt University Medical Center (Tennessee); Beth Heinz, service line executive, mental health and addiction services, M Health Fairview (Minnesota); Garrett Hoover, president and chief operating officer, Carroll Hospital and senior vice president, LifeBridge Health (Maryland); Tracey Lavallias, executive director, behavioral health service line, Lancaster General Health (Pennsylvania); Tamara Player, CEO, Polara Health (Arizona);and Jesse Tamplen, vice president, behavioral health services, John Muir Health (California).

The committee advises AHA on policy and advocacy, and provides a forum for strategic discussion of issues important to behavioral health providers and the field. For more information on AHA’s work on behavioral health, click here.
 

Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Headline
David Stark, chief of government and external affairs and philanthropy officer at UnityPoint Health, shares how a major philanthropic investment is helping…
Headline
The Substance Abuse and Mental Health Services Administration has released an advisory examining innovative solutions to close gaps in behavioral health care…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…